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Nephropathia epidemica (NE) is a hemorrhagic fever with
renal syndrome caused by Puumala hantavirus. Its long-term
prognosis is considered favorable. There are, however, some
reports about subsequent hypertension, glomerular
hyperfiltration, and proteinuria after previous hantavirus
infection. Therefore, we studied 36 patients 5 and 10 years
after acute NE, with 29 seronegative controls. Office blood
pressure, ambulatory 24-h blood pressure (ABP), glomerular
filtration rate (GFR), and proteinuria were examined.
Hypertensive subjects were defined as those patients having
increased ambulatory or office blood pressure, or receiving
antihypertensive therapy. Office blood pressure was used to
define hypertension only if ABP was not determined. At 5
years, the prevalence of hypertension was higher among NE
patients than in controls (50 vs 21%, P¼ 0.020). At 10 years,
the difference between the groups was no more significant
(39 vs 17%, P¼ 0.098). Five years after NE, patients showed
higher GFR (121719 vs 109716 ml/min/1.73 m2, P¼ 0.012)
and urinary protein excretion (0.19 g/day, range 0.12–0.38 vs
0.14 g/day, range 0.09–0.24, P¼o0.001) than controls. At 10
years, there were no more differences in GFR or protein
excretion between the groups (GFR: 113720 vs 108717 ml/
min/1.73 m2, P¼ 0.370; proteinuria: 0.14 g/day, range
0.07–0.24 vs 0.13 g/day, range 0.06–0.31, P¼ 0.610). In
conclusion, the 10-year prognosis of NE is favorable, as
glomerular hyperfiltration and slight proteinuria detected at
5 years disappeared during the longer follow-up. However,
the possibility exists that NE may predispose some patients
to the development of hypertension.
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Nephropathia epidemica (NE) is a mild type of hemorrhagic
fever with renal syndrome caused by Puumala virus. The
virus is a member of the hantavirus genus in the
Bunyaviridae family carried by bank voles (Clethrionomys
glareolus).1 NE is common in Northern Europe, European
Russia, and in parts of Central-Western Europe.1 Approxi-
mately 1000 serological diagnoses of Puumala virus infection
are made in Finland annually.2 However, the seroprevalence
in the Finnish population is 5%, implying that most
infections are subclinical or remain undiagnosed.
NE is the most common cause of acute nephritis in
Finland.3 The clinical picture of the disease varies in severity,
and the usual symptoms are high fever, headache, and back
and abdominal pain.4–6 Renal involvement causes protein-
uria, hematuria, and oliguria followed by polyuria.4–6 A
minority of patients need transient dialysis treatment.6 The
most characteristic histopathological lesion in renal biopsy is
acute tubulointerstitial nephritis.7 Glomerular alterations are
mild despite often heavy proteinuria. Complete recovery is
the usual outcome.4–6
The long-term prognosis of hemorrhagic fever with renal
syndrome has been considered favorable.4,5,8 However, we
previously found that 5 years after acute NE, the patients had
higher systolic blood pressure, glomerular filtration rate
(GFR), and more proteinuria than healthy controls.9 A study
by one group in the United States suggests that previous
hantavirus infection might be associated with an increased
risk of hypertensive renal disease.10
The aim of the present study was to investigate the 10-year
prognosis of NE. We continued our previous study on the
5-year prognosis of acute NE9 by inviting the same patients
and controls to a follow-up visit. We were interested in
putative differences in blood pressure and renal function
between the patients and controls, and changes in those
variables during the follow-up.
RESULTS
Clinical and laboratory data
The clinical and laboratory variables 5 and 10 years after
acute NE are shown in Table 1. There was no difference in
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body mass index (BMI) between the patients and controls at
5 years. However, at 10 years, the patients had higher BMI
than controls, as BMI had increased 1.8 units in them.
Fasting blood glucose was also slightly higher in patients than
controls at 10 years, but there was no difference in
hemoglobin A1c values. Diabetes controlled by diet had been
diagnosed in two patients during the time from 5 to 10 years
after acute NE. At 10 years, we found one patient having
undiagnosed diabetes (blood hemoglobin A1c 7.1%). Alcohol
intake, smoking, or exercise habits did not differ between the
patients and controls (data not shown).
Neither patients nor controls displayed any pathological
Q-waves or ST-T-wave alterations in electrocardiogram
recordings, 5 and 10 years after NE. The sum of SV1 and
RV5 did not differ between patients and controls at 5 or 10
years (25 and 23 mm, respectively, at 5 years, P¼ 0.418; 24
and 23 mm, respectively, at 10 years, P¼ 0.433).
Blood pressure
None of the patients or controls received antihypertensive
therapy at 5 years. At 10 years, 7/36 (19%) patients and 2/29
(7%) controls were treated with antihypertensive drugs
(P¼ 0.172, Fisher’s exact test). The patients had started
therapy 5–11 years after NE. The antihypertensive medica-
tions were angiotensin-converting enzyme inhibitors, angio-
tensin II antagonists, beta-blockers, calcium channel
blockers, and diuretics. All these subjects continued their
medication during the examinations at 10 years. It is of note
that the ambulatory 24-h blood pressure (ABP) monitoring
results did not change if the subjects using antihypertensive
therapy were excluded from the statistical analyses.
At 5 years, 2/36 patients did not undergo ABP monitoring,
but their office blood pressure was normal. At 10 years, two
out of five patients, who did not undergo ABP monitoring,
had elevated office blood pressure (166/100 and 158/94 mm
Hg). One control with no ABP monitoring at 10 years
showed office blood pressure of 140/90 mm Hg.
The results of ABP monitoring, 5 and 10 years after acute
NE, are shown in Table 2. The patients had higher systolic
(Figure 1a) and diastolic blood pressure than controls at 5
years, but there were no significant differences in ABP at 10
years. The blood pressure of patients was stable at 5 and 10
years (systolic blood pressure 123713 vs 124713 mm Hg,
P¼ 0.881; diastolic blood pressure 7977 vs 8078 mm Hg,
P¼ 0.921, paired-samples t-test). However, systolic blood
pressure of controls increased during the follow-up from 5 to
10 years (11679 vs 120711 mm Hg, P¼ 0.006). Diastolic
blood pressure of controls did not change (7577 vs
7778 mm Hg, P¼ 0.208).
In 24-h ABP monitoring, 17/34 (50%) patients and 6/29
(21%) controls had hypertension (mean ABP X133/82 mm
Hg11) at 5 years (P¼ 0.020, Fisher’s exact test). At 10 years,
ABP monitoring showed hypertension in 6/31 (19%) patients
and 2/28 (7%) controls (P¼ 0.259).
According to the applied definition of the prevalence of
hypertension, there were 17/34 (50%) patients and 6/29
(21%) controls having hypertension at 5 years (P¼ 0.020,
Fisher’s exact test). At 10 years, 14/36 (39%) patients and
5/29 (17%) controls had hypertension (P¼ 0.098).
In the whole material, the BMI of hypertensive subjects
was higher than that of normotensive subjects at 10 years (30
vs 27, P¼ 0.019, independent samples t-test). BMI had a
weak direct correlation with both systolic and diastolic mean
blood pressure in ABP (r¼ 0.41, P¼ 0.001 and r¼ 0.28,
P¼ 0.034, respectively, Pearson’s correlation), but no corre-
lation with blood glucose (r¼ 0.20, P¼ 0.120).
Renal function and proteinuria
Table 2 and Figure 1b show that 5 years after NE the patients
had higher GFR than controls, but during the follow-up from
5 to 10 years, GFR of patients decreased to the same normal
level as in controls. The decrease in GFR of patients from 5 to
10 years was significant (121719 vs 113720 ml/min/
1.73 m2, P¼ 0.023, paired-samples t-test). Effective renal
plasma flow and filtration fraction did not change in patients
or in controls.
As shown in Table 2 and Figure 1c, the NE patients had
slightly higher urinary protein excretion than controls at 5
Table 1 | Clinical and laboratory findings of patients and controls 5 and 10 years after acute NE
5 years 10 years
Patients (N=36) Controls (N=29) P Patients (N=36) Controls (N=29) P-value
Age (years) 45710 46710 0.498 50710 51710 0.442
Gender (males/females) (n) 20/16 14/15 0.622 — — —
BMI (kg/ m2) 27 (19–48) 26 (21–34) 0.215 29 (22–44) 26 (21–33) 0.003
Blood hemoglobin (g/l) 142711 139711 0.397 142713 140712 0.581
Blood leukocytes (109/l) 5.971.6 5.571.5 0.295 6.171.9 6.071.8 0.775
Serum creatininea (mmol/l) 77711 81714 0.179 68711 72714 0.252
Serum urea (mmol/l) 5.171.1 4.871.2 0.342 5.171.2 5.071.1 0.713
Serum total cholesterol (mmol/l) 5.2 (3.8–7.1) 5.3 (4.0–7.8) 0.445 5.6 (4.3–8.8) 5.3 (4.0–7.9) 0.213
Serum triglycerides (mmol/l) 1.3 (0.5–3.7) 1.5 (0.5–3.6) 0.347 1.4 (0.5–5.1) 1.2 (0.5–2.4) 0.176
Fasting blood glucose (mmol/l) 4.570.5 4.570.4 0.838 5.170.6 4.670.4 0.002
Blood hemoglobin A1c (%) ND ND — 5.4 (4.9–7.1) 5.4 (4.9–6.0) 0.764
Urine osmolality (mOsm/kg) 7587179 7307227 0.585 7217242 6377237 0.166
BMI=body mass index; ND=no data; NE=nephropathia epidemica.
Mean7s.d. are given for normally distributed variables and median (range) for skew-distributed variables.
aDifferent determination method of serum creatinine at 5 and 10 years (see Materials and Methods).
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years. Ten years after acute disease, there was no more
difference between the groups, as the slight proteinuria of
patients detected at 5 years disappeared during the longer
follow-up (0.19 (0.12–0.38) vs 0.14 (0.07–0.24) g/day,
P¼o0.001, Wilcoxon’s test). Furthermore, at 5 years the
prevalence of elevated urinary a1-microglobulin excretion
was also higher in patients than in controls (7/34 vs 1/29,
P¼ 0.060, Fisher’s exact test), whereas at 10 years there was
no difference between the groups (4/36 vs 2/29, P¼ 0.684).
The quantities of overnight urinary excretions of immuno-
globulin G or albumin did not differ between the groups at 5
or 10 years (data not shown).
DISCUSSION
This is the first report confirming the present clinical view
that the long-term prognosis of Puumala hantavirus-induced
acute tubulointerstitial nephritis is favorable. The increased
GFR and urinary protein excretion, detected at 5 years, were
no more present at 10 years after acute NE. Nevertheless, NE
may predispose some patients to the elevation of blood
pressure several years after the acute disease. Although the
present study was carried out with a relatively small number
of subjects, this report is still the largest prospective clinical
follow-up trial about the long-term effects of acute NE on
blood pressure. All subjects from the original9 cohort were
not available for examinations at 10 years, as 10 patients and
nine controls were lost to follow-up. However, if the results at
5 years on GFR, ABP, and proteinuria were calculated
excluding the patients lost to follow-up, the outcome was
identical whether these individuals were included or
excluded. Thus, the remaining patients can be considered
to have well represented the original study cohort.
In a combined analysis that defined hypertensive subjects
as those having antihypertensive therapy, high blood pressure
in ABP monitoring, or high office blood pressure, there were
more hypertensive subjects in the patients than in the
seronegative controls 5 years after acute NE. At 10 years, the
difference between the groups was no more significant.
Correspondingly, in the ABP monitoring, systolic blood
pressure was higher in patients than in controls at 5 years, but
there were no differences between the groups at 10 years. The
Table 2 | Comparisons of ambulatory blood pressure, renal function, and proteinuria in patients and controls 5 and 10 years
after acute NE
5 years 10 years
Patients (N=34–36) Controls (N=28–29) P-value Patients (N=31–36) Controls (N=28–29) P-value
Means of 24-h (mm Hg)
SBP 123713 11679 0.010 124713 120711 0.208
DBP 7977 7577 0.026 8078 7778 0.134
Means daytime (mm Hg)
SBP 127713 12079 0.024 128713 124711 0.222
DBP 8178 7877 0.066 8278 7978 0.132
Means night time (mm Hg)
SBP 106712 10079 0.016 108716 105713 0.435
DBP 6877 6577 0.108 69710 6879 0.601
GFR (ml/min/1.73 m2) 121719 109716 0.012 113720 108717 0.370
ERPF (ml/min/1.73 m2) 6277105 6157112 0.652 6067115 5927109 0.623
FF (%) 2073 1873 0.071 1974 1973 0.670
UPE (g/day) 0.19 (0.12–0.38) 0.14 (0.09–0.24) o0.001 0.14 (0.07–0.24) 0.13 (0.06–0.31) 0.610
DBP=diastolic blood pressure; ERPF=effective renal plasma flow; FF=filtration fraction; GFR=glomerular filtration rate; NE=nephropathia epidemic; SBP=systolic blood
pressure; UPE=urinary protein excretion.
Mean7s.d. are given for normally distributed variables and median (range) for skew-distributed variables.
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Figure 1 | (a) The 24-h systolic blood pressure, (b) glomerular
filtration rate, and (c) urinary protein excretion in controls and
patients examined 5 and 10 years after acute NE. The results with
normal distribution (a and b) are depicted as means (’), s.e. of the
mean (box), and s.d. (whiskers); results with skewed distribution (c)
are depicted as medians (line inside box), 25th and 75th percentile
(box), and range (whiskers); *Po0.05 vs controls at 5 years, wPo0.05
vs patients at 5 years.
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systolic blood pressure of controls had increased during
the study period, probably as a reflection of aging of the
study subjects. In contrast, the blood pressure of patients
had remained unchanged from 5 to 10 years. Because of
ethical reasons, all subjects receiving antihypertensive
therapy continued to use their medication during the
examinations at 10 years after NE. As there were more
medicated patients than controls at 10 years after NE, this
may have influenced the results of the blood pressure
measurements.
There have been some reports of a possible association
between previous hantavirus infection and subsequent
hypertension.4,10,12–14 La¨hdevirta et al.12 from Finland have
reported that one out of nine patients presented with
hypertension 4–5 years after acute NE. In a study from the
Korean War, two out of 13 patients seemed to have
hypertensive vascular disease after hemorrhagic fever with
renal syndrome.13 According to a seroepidemiological study
from Baltimore, infection with rat-borne Seoul-like hanta-
virus showed a consistent association with hypertensive renal
disease.10 Furthermore, a study from Sweden reported a
significant association between Puumala virus antibody
positivity and hypertension in patients over 60 years of age,
although such an association was not found in younger
individuals.8
In the present study, BMI of the patients and controls was
similar at the time of recruitment of the study population at
5 years after acute NE. However, at 10 years, BMI was
significantly higher in patients than controls. Although
obesity is an important factor predisposing to the elevation
of blood pressure, it does not explain the development of
hypertension in controls between 5 and 10 years in this study,
as their BMI remained stable. In the whole study population,
hypertensive subjects were more obese than normotensive
subjects, and BMI showed a direct association with both
systolic and diastolic blood pressure.
Essential hypertension does not have a single cause, but
kidneys seem to have an important role in its pathogenesis.15
It has been proposed that renal microvascular disease,
accompanied by interstitial inflammatory and tubular
changes, plays a critical role in the genesis of hypertension.16
Any factor causing renal vasoconstriction, especially in the
outer medulla and the adjacent cortex, may induce this
injury. Theoretically, hantavirus infection might act as an
initiating factor for renal vasoconstriction. Autopsy studies
have shown that the renal medulla is the most affected part of
the kidney in hemorrhagic fever with renal syndrome.17 The
most characteristic histopathological lesions in renal biopsies
of NE patients have been congestion and hemorrhage around
the vessels in the outer medulla or corticomedullary junction
with interstitial inflammatory cell infiltrates.4,7,18 Increased
expression of endothelial adhesion molecules, tumor necrosis
factor-a, tumor growth factor-b, and platelet-derived growth
factor has been detected to colocalize with the inflammatory
cell infiltrates.19 Hantaviruses seem to have a special
predilection to infect vascular endothelial cells.20,21
The glomerular hyperfiltration of the patients, detected at
5 years after NE, had subsided at 10 years, whereas the GFR of
the controls remained stable throughout the study. Conse-
quently, no difference in GFR was detected between the
patient and the control groups at 10 years. Glomerular
hyperfiltration is most widely known as a feature of early
diabetic nephropathy.22,23 There is also some evidence of
glomerular hyperfiltration in adult polycystic kidney dis-
ease,24 as well as in essential hypertension.25 However, to our
knowledge, there are no previous reports of glomerular
hyperfiltration after acute tubulointerstitial nephritides. It
seems plausible that distinct pathophysiological mechanisms
could underlie the increases in GFR under different disorders.
In this study, the underlying mechanisms of glomerular
hyperfiltration at 5 years after NE cannot be determined from
the available set of data, although one possibility is that this
could be a secondary phenomenon to the elevated systolic
blood pressure. It remains to be investigated whether the GFR
of NE patients will remain normal or show accelerated
decline during a still longer follow-up.
In the present study, mild functional tubular defects were
detected 1–6 years after acute NE, in concert with earlier
studies.4,12,26,27 The mild proteinuria, especially elevated
urinary a1-microglobulin excretion that reflects tubular
dysfunction, also disappeared within 10 years after acute
NE. Altogether, it is noteworthy that the present patients
showed concurrent increases in blood pressure, GFR, and
urinary protein excretion at 5 years after acute NE, whereas
none of these variables differed from those in the healthy
controls at 10 years after acute NE.
In summary, the 10-year prognosis after acute NE seems
to be favorable, although NE may predispose some patients
to the development hypertension. It is not known whether
the glomerular hyperfiltration, observed 5 years after acute
NE in some patients, is an early sign of renal injury that could
eventually lead to a decline of GFR. Further follow-up will be
needed to establish the final outcome.
MATERIALS AND METHODS
Study population and protocol
Originally, there were 46 patients and 38 controls in the study
concerning the 5-year prognosis of acute NE.9 Of them, 10 years
after NE, we were able to re-examine 36 patients (20 males and 16
females) aged from 32 to 68 (mean 50) years and 29 controls (14
males and 15 females) aged from 30 to 69 (mean 51) years. The
patients had been originally hospitalized owing to serologically
verified NE28 during the years 1990–1995 at the Department of
Internal Medicine, Tampere University Hospital. They were
examined 3–7 (mean 5)9 and 8–13 (mean 10) years after acute NE.
The controls were recruited by an open announcement as described
previously.9 At 5 years, the patient and control groups were
comparable to each other with respect to age, gender, and BMI. A
detailed clinical survey of all subjects was carried out on an
outpatient basis from February to May 2003 at Tampere University
Hospital.
The following diseases before NE were recorded in five patients:
ankylosing spondylarthritis in two, and coronary heart disease,
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bronchial asthma, and chronic schizophrenia in one each. The
patient with asthma had also hypothyroidism. One of the controls
had hypothyroidism. All these subjects continued to use their
regular medication over the study period.
All subjects gave informed consent before participation, and the
study was approved by the Ethics Committee of Tampere University
Hospital.
Laboratory specimens and electrocardiogram
Blood specimens were obtained in the morning after a minimum
12-h fast. During the years 1990–1995, serum creatinine, urea,
cholesterol, triglycerides, and blood glucose were analyzed by Vitros
(Johnson & Johnson, Rochester, NY, USA) and in 2003 by Cobas
Integra Analyzer (F Hoffmann-LaRoche Ltd, Basel, Switzerland).
Serum creatinine concentrations that were determined in 2003
showed 10% lower values than those analyzed during the years
1990–1995 owing to above change of the determination method.
Blood cell count was determined by H2 or H3 hematological
analyzer (Bayer Corporation, Tarrytown, NY, USA) and blood
hemoglobin A1c by Roche Diagnostics (Mannheim, Germany).
Negative Puumala virus serology of the controls was confirmed.28
The 24-h, nightly and daytime urinary protein excretion, and the
overnight urinary excretion of a1-microglobulin, albumin, and
immunoglobulin G were measured. The spot samples of morning
urine were collected after a minimum of 12 h of fasting and analyzed
for osmolality, erythrocytes, leukocytes, albumin, nitrite, glucose,
pH, and ketones. Osmolality of urine was measured by the
Advanced CryomaticTM Osmometer (Advanced Instruments Inc.,
Needham Heights, MA, USA). Hematuria was defined as a positive
dipstick test for erythrocytes and over two erythrocytes per high-
power field. Overnight urinary excretion of a1-microglobulin
X7 mg/min, albumin X11mg/min, and immunoglobulin G
X5 mg/min were considered abnormal, based on the healthy
reference material of our laboratory.9
Electrocardiograms were evaluated according to the Minnesota
codes. Left ventricular mass was evaluated by the sum of the height
of the S-wave in lead V1 (SV1) and the R-wave in lead V5 (RV5) of a
12-lead resting ECG. BMI was calculated by dividing weight (kg) by
the square of height (m2).
Determination of renal function
GFR was determined by the single injection method as a plasma
clearance of 51Cr-ethylenediaminetetraacetic acid after a light
meal and expressed in values normalized for body surface area.
Effective renal plasma flow was estimated by clearance of
131I-hippurate. The filtration fraction was calculated as the quotient
of GFR and effective renal plasma flow. Two patients at 5 years
refused these examinations. At 10 years, GFR and effective renal
plasma flow were not determined in one patient and one control
owing to pregnancy.
Blood pressure monitoring
The ABP was measured with a fully automatic recorder. The cutoff
point that defined hypertension was a 24-h mean ABPX133/82 mm
Hg according to a large population study.11 Office blood pressure
was also measured, and the cutoff point for hypertension wasX140/
90 mm Hg according to the WHO/ISH guidelines.29 We defined
patients as hypertensives if they were on antihypertensive therapy, or
had mean ABP X133/82 mm Hg, or had office blood pressure
X140/90 mm Hg. Office blood pressure was used to define
hypertension only if ABP monitoring was not determined.
Statistical analysis
To describe the data, means and s.d. are given for normally
distributed variables, and medians and ranges for skew-distributed
continuous variables. Groups were compared using independent
sample t-tests for normally distributed variables, and Mann–Whit-
ney U-tests for skewed variables. Categorical data were analyzed by
w2 test or by Fisher’s exact test. The results of 5- and 10-year
prognosis of NE were compared with paired-samples t-test for
normally distributed variables, and with Wilcoxon’s matched pairs
signed rank-sum test for skewed variables. Associations between
BMI and blood pressure, and BMI and blood glucose were analyzed
using Pearson’s correlation. All tests were two sided and analyses
were performed with the SPSS for Windows version 13 (SPSS Inc.,
Chicago, IL, USA).
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